文献速递糖尿病肥胖与代谢综合征

抗抑郁药使用与抑郁症合并糖尿病患者晚期糖尿病结局的关联

Associations Between Antidepressant Use and Advanced Diabetes Outcomes in Patients with Depression and Diabetes Mellitus.
PubMed 文献 · J Clin Endocrinol Metab · 2021-01-01

本研究基于台湾全民健康保险数据库开展全国性回顾性队列研究,纳入36 276例抑郁症合并新治疗糖尿病患者,分析6个月内抗抑郁药使用模式与晚期糖尿病并发症及全因死亡的关系。结果显示,与不良使用相比,规律使用抗抑郁药与降低大血管并发症和全因死亡风险相关,但与微血管并发症无关。

要点

  • 规律使用抗抑郁药与抑郁症合并糖尿病患者大血管并发症风险降低相关。
  • 规律使用抗抑郁药与全因死亡风险降低相关。
  • 临床应重视抑郁症合并糖尿病患者的抗抑郁治疗依从性。

核心结论

  • 与不良使用抗抑郁药相比,规律使用与晚期糖尿病并发症风险降低相关。

研究设计与样本

  • 全国性回顾性队列研究,纳入36 276例抑郁症合并新治疗糖尿病患者,使用台湾全民健康保险数据库。

主要发现

  • 与不良使用相比,规律使用抗抑郁药与大血管并发症风险降低0.92倍相关,与全因死亡风险降低0.86倍相关,但与微血管并发症无关。
  • 规律使用选择性5-羟色胺再摄取抑制剂与大血管并发症风险降低0.83倍和全因死亡风险降低0.75倍相关。
  • 规律使用三环类或四环类抗抑郁药与全因死亡风险降低0.78倍相关。
  • 规律使用苯二氮䓬类药物与糖尿病结局无关联。

临床怎么用

  • 临床医生应强调抑郁症合并糖尿病患者的抗抑郁治疗依从性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Comorbid depression in patients with diabetes deteriorates the prognosis. Antidepressants might attenuate the adverse effects of depression; however, they are associated with cardiometabolic adverse effects. OBJECTIVE: This study aimed to explore the association between antidepressant treatment and advanced diabetic complications and mortality among patients with depression and diabetes mellitus. METHODS: We conducted a nationwide retrospective cohort study of 36 276 patients with depression and newly treated diabetes mellitus using Taiwan's universal health insurance database. Antidepressant treatment patterns within a 6-month window were classified into none, poor, partial, and regular use, and we accounted for time-dependent variables in the Cox proportional hazards regression analysis with adjustment for time-dependent comorbidity and concomitant use of medications. Different classes of antidepressants were compared. Macro- and microvascular complications, as well as all-cause mortality, were the main outcomes. Benzodiazepines were chosen as negative control exposure. RESULTS: Compared with poor use of antidepressants, regular use was associated with a 0.92-fold decreased risk of macrovascular complications and a 0.86-fold decreased risk of all-cause mortality but not associated with microvascular complications. Regular use of selective serotonin reuptake inhibitors was associated with a 0.83- and 0.75-fold decreased risk of macrovascular complications and all-cause mortality, respectively. Regular use of tricyclic or tetracyclic antidepressants was associated with a 0.78-fold decreased risk of all-cause mortality. Regular use of benzodiazepine showed no association with diabetic outcomes. CONCLUSION: Regular antidepressant use was associated with lower risk of advanced diabetic complications compared with poor adherence. Clinicians should emphasize antidepressant treatment adherence among patients with depression and diabetes mellitus.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Wu CS, Hsu LY, Pan YJ, et al. Associations Between Antidepressant Use and Advanced Diabetes Outcomes in Patients with Depression and Diabetes Mellitus. J Clin Endocrinol Metab. 2021. PMID: 34259856. doi:10.1210/clinem/dgab443

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。